Search
SCYNEXIS Inc
SCYXAdd to Watchlist
3.800USD
-0.010-0.26%
Close 10-27 16:00（ET）
37.81MMarket Cap
LossP/E TTM
SCYNEXIS Inc (SCYX) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to SCYNEXIS Inc in the past month.
Buy
1 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
36.333USD+853.63%
SCYX Analyst Recommendation Trends
In the current month, SCYX has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SCYX average Analyst price target in the last month is 36.333.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
3
3
3
3
3
SCYX Analyst Rating for Peer Comparison
Updated: Oct 27, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, SCYX EPS is projected to reach -0.613 in FY2026Q3, following reported EPS of 0.626 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.01
-0.99
-0.51
-0.61
-0.53
Actual
0.24
-3.34
0.63
--
--
Surprise
-76.11%
-238.91%
+223.47%
--
--
FAQs
What is SCYNEXIS Inc's expected revenue for the next quarter?
SCYNEXIS Inc's expected revenue is 87.00K.
What is SCYNEXIS Inc's price target?
Analysts forecast that SCYNEXIS Inc's price target is USD 36.33, with the highest forecast at USD 44.00 and the lowest forecast at USD 32.00.
How have SCYNEXIS IncSCYX's recent earnings per share performed?
The market expectation was USD 0.63, while SCYNEXIS IncSCYX's earnings per share (EPS) for the previous quarter was USD -3.34. EPS for the next quarter is expected at USD -0.61.
What is the analyst rating for SCYNEXIS Inc?
Based on the ratings of SCYNEXIS Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.